FDA Holds Off Approval of New Merck Drug (Reuters) Reuters - Merck   Co.  on Friday said\U.S. regulators have decided not to approve the company's\experimental arthritis drug, the successor to its recalled\Vioxx pill, until more safety and effectiveness data are\obtained.